Business Development Life Sciences

Ron Chabot

Boston, MA 207-***-**** *******.*********@*****.***

LinkedIn: linkedin.com/in/ron-chabot-855922b

PROFILE SUMMARY

Strategic and entrepreneurial business development executive with 20+ years of leadership in Life Sciences, Digital Health & AI. Deep expertise across all phases of clinical trials from early development through commercialization, as well as across medical devices, biologics, CGT and pharmaceuticals. Proven record in building high-value partnerships with clinical and commercial operations teams and decision-makers at emerging biotechs and established pharma companies. Extensive network of C-level and senior support executives in Life Sciences. Experienced speaker and published thought leader in AI for healthcare. PROFESSIONAL EXPERIENCE

Business Development Consultant - AI & Life Sciences Boston, MA Aug 2023 - Present

- Represent leading firms including PrescriberPoint (incubated by Eli Lilly & BCG), an AI platform to increase pharmaceutical brand prescribers.

- Forge strategic partnerships and drive revenue growth across healthcare and HCP engagement. Senior Business Development Manager - Converge Consulting Cambridge, MA Dec 2020 - Jul 2023

- Advised pharma and CGT clients on supply chain, CMC, and technical operations across all drug development phases.

- Generated $5.2M ($6.2 M including 1M bid won) in new revenue and secured 14 new clients.

- Created SOWs, led competitive bid processes (won a 1M bid), and managed cross-functional execution.

Independent Business Development & Product Consultant Boston, MA Oct 2014 - Nov 2019

- Delivered clinical, commercialization and regulatory strategy for startups in the life sciences sector.

- Led CME-accredited events and recruited key opinion leaders to support product launches. Founder & CEO - Galaxy AI Innovations, Inc. Boston, MA 2017 - 2019

- Developed a digital therapeutic AI chatbot for substance use disorders (SUD), earning 3rd place at AI World North America. Received a "Thank you" Letter from the President of the United States, White House.

- Presented at the World Healthcare Congress and selected for a top incubator focused on digital health and AI.

GM / VP of Business Development - ETIAM Healthcare Corp. Cambridge, MA Nov 2011 - Sep 2014

- Spearheaded U.S. market growth strategy for telehealth solutions.

- Grew sales by 40% and improved SEO/marketing, increasing qualified leads by 55%, growing revenue by 4.8M.

- Secured contracts with major health systems like Cleveland Clinic; spoke on global panel broadcast for CCF and ETIAM virtually to 67 countries about our new patient portal. President & COO - Mizuho America, Inc. Boston / Japan May 2005 - Feb 2009

- Directed all U.S. operations, P&L, marketing, and sales for a top neurosurgical device manufacturer.

- Grew revenue from $6.1M to $14M through new product launches and team expansion.

- Drove development of the T2 aneurysm clip and nasal-access neurosurgical tools-now market leaders.

General Manager & Marketing Manager - Integra LifeSciences Plainsboro, NJ Apr 2002 - Apr 2005

- Managed a $25M neurosurgery business unit and launched new innovations across product lines. Increased sales by 17M.

Managed a neurosupplies and cranial plate and screw business and increased revenue by 8M.

- Introduced a novel hydrocephalus shunt valve, expanding into the elderly market.

- Boosted company market cap by $268M in one day through innovation and strategic marketing. Director of Sales & Marketing / Product Manager - Radionics (acquired by Integra) Burlington, MA Jun 1999 - Mar 2002

- Oversaw global sales/marketing of a portfolio of neurology and pain management technologies. Increased sales of epilepsy and shunt products from zero to 11 M. Grew pain management business by 18M.

- Executed product launches and expanded national and international distribution networks. EDUCATION

Bachelor of Arts in Business Administration

Skidmore College, Saratoga Springs, NY 1988

KEY SKILLS

- Strategic Business Development & Growth

- Product Management & Commercialization

- Clinical Trials, Drug Development, QMS, Regulatory Strategy

- Telehealth, SaaS & Digital Health Technologies

- AI & Robotics in Healthcare

- Cross-Functional Leadership

- Global Sales & Channel Expansion

- KOL Development & Medical Education

- Go-To-Market Strategy

- Innovation & Market Disruption

ADDITIONAL INFORMATION

- Publications: Contributed to Harvard Business Review, September 2024 - "Connecting Patients to Therapies and Devices Faster with AI"

- Speaker: Guest at AI, MedTech, university conferences and World Congresses

- Network: Connected to 25K+ professionals, including C-suite and VP-level executives in clinical development, clinical operations, and commercial roles across emerging biotech and global life sciences organizations

Contact this candidate